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LACK OF SCLEROSTIN PROMOTES OSTEOARTHRITIS BY ACTIVATING
CANONICAL AND NON-CANONICAL WNT PATHWAYS
W. Bouaziz, T. Funck-Brentano, H. Lin, C. Marty, E. Hay, M. Cohen-Solal.
Inserm U1132, Paris, France
Purpose: Sclerostin is a Wnt inhibitor produced by mineralizing cells
such as osteocytes. Sclerostin is also expressed in OA chondrocytes and
therefore might regulate the cartilage homeostasis in osteoarthritis
through the inhibition of Wnt pathways. We aimed here to assess the
role of sclerostin in the chondrocyte metabolism and the development
of osteoarthritis in SOST-deﬁcient mice.
Methods: Joint instability was induced by partial transsection of the
meniscus (MNX) in 10 week-old SOST-KO and wild type (WT) mice.
Mice were sacriﬁced at 4, 6 or 9 weeks after MNX.We analyzed: 1) bone
parameters such as bone volume/tissue volume (BV/TV) at the medial
femoral condyle, 2) the osteophyte volume by microCT, 3) the cartilage
damage using OA score and 4) the expression of matrix proteins. The
role of sclerostin in chondrocyte metabolism was investigated in pri-
mary murine chondrocytes culturedwithWnt3a and sclerostin (RT-PCR
and WB). Functional effect was assessed by the release of proteoglycan
content in the culture supernatant and the accumulation of GAGs by
Alcian blue staining. We next investigated the role of b-catenin / JNK
pathway using SP600125 inhibitor.
Results: Sclerostin expression was restricted to the calciﬁed cartilage
and osteocytes in WT mice and was enhanced with the development of
OA. In sham-knees, cartilage structure was preserved in SOST-KO mice
at any time despite a marked high BV/TV. MNX resulted in a higher OA
score in SOST-KOmice than inWTatWeek 4 (6.66 0.57 vs 3.25 0.95,
p<0.05) and Week 6 (11  1 vs 7  0.81, p<0.05), along with an
increased expression in type X collagen and Adamts-4 that suggested an
enhanced catabolism of chondrocytes. However, the osteophyte volume
was not affected by the lack of sclerostin at Week 4 (0.033  0.019 vs
0.024  0.01, p: NS) and at Week 6 (0.023  0.01 vs 0.02  0.01, p: NS).
In primary murine chondrocytes, Wnt3a reduced the proteoglycan
release which was rescued by sclerostin. Wnt3a increased the expres-
sion of Adamts-4 & -5, MMP-3 & -13 and type X collagen, while this
effect was totally abolished by sclerostin through an inhibition of the
Wnt canonical pathway. Moreover, Wnt3a promoted the phosphor-
ylation of JNK which was inhibited by sclerostin. We further inves-
tigated whether sclerostin-induced inhibition of JNK affects
chondrocyte anabolism. In Wnt-induced chondrocytes, sclerostin res-
cued the accumulation of GAGs and the expression of the anabolic
genes when JNK pathway was inhibited. In contrast, sclerostin did not
affect the CamK pathway.
Conclusions: Lack of sclerostin results in cartilage damage and disrupts
the balance of anabolism/catabolism in OA induced by joint instability.
Sclerostin inhibits both Wnt canonical pathway and the non canonical
JNK pathway, thereby preserving the chondrocyte metabolism. These
data suggest an important role of sclerostin in cartilage integrity in OA.
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MICE LACKING ONCOSTATIN M RECEPTOR EXPRESSION SHOW
REDUCED SYNOVIAL INFLAMMATION AND CARTILAGE DAMAGE,
BUT INCREASED BONE LOSS IN RESPONSE TO JOINT INJURY
B.A. Tonkin y, N. Jansz y, J. Johnson y, E. Romas z, N.A. Sims y,x,
N.C. Walsh y,x. y St Vincent’s Inst. of Med. Res., Melbourne, Australia;
zDept. Rheumatology, St Vincent’s Hosp., Melbourne, Australia; xDept
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Purpose: Regardless of the inciting event, mild inﬂammation within the
synovium, progressive loss of articular cartilage, osteophyte formation
and accrual of subchondral bone are characteristic features of osteo-
arthritis (OA). The cytokine oncostatinM (OSM) is found at elevated levels
in human OA synovial ﬂuid and is a candidate for contributing to OA
pathogenesis. In synovialﬁbroblasts and osteoblastsOSM, signaling via its
ligand-speciﬁc receptor, OSMR, induces expression of pro-inﬂammatory
cytokines such as IL-6, cartilage degrading enzymes and the pro-osteo-
clastic factor, RANKL. We have also shown that OSM can augment IL-1
actions in synovial ﬁbroblasts by increasing expression of IL-1R1.We
hypothesized that,mice lackingexpression of OSMR (OSMRKOmice)may
be protected from injury-induced osteoarthritic-joint damage.
Methods: 12-week old male OSMR KO mice and their wildtype litter-
mates (OSMR WT) underwent surgical transection of the medial
meniscotibial ligament (DMM) or sham surgery on the right knee. Hindlimbs were collected and analysed at 8 weeks post-surgery. Bone
structure was analysed by ex-vivo micro-CT (Skyscan). Aggrecan loss
and cartilage damage were assessed according to the OARSI histologic
scoring scheme. Synovial inﬂammation was assessed using a modiﬁed
scoring scheme typically used for inﬂammatory arthritis. Statistics: 2-
way ANOVA, Sidak multiple comparisons post-hoc tests.
Results: At 8 weeks post-surgery in OSMR WT mice, increased loading
within the medial compartment of the tibia resulted in a focal increase
in medial subchondral bone (bone volume/tissue volume, BV/TV) in
DMM tibiae compared to sham tibiae. In contrast, OSMR KO mice
showed reduced BV/TV at this site in DMM tibiae compared to sham
tibiae (p<0.01). Furthermore, tibial metaphyseal trabecular BV/TV was
also reduced in OSMR KO DMM tibiae compared to sham tibiae
(p<0.01); this was not observed in OSMRWT mice. Although OSMR KO
mice showed similar levels of DMM-induced aggrecan loss compared to
OSMR WT mice, structural cartilage damage was reduced (p<0.05) in
the OSMR KO mice. Furthermore OSMR KO mice also showed reduced
synovial inﬂammation (p<0.05) compared to OSMR WT mice.
Conclusions: Together our data indicate that OSM signalling via OSMR
contributes to synovial inﬂammation and cartilage destruction in
response to joint injury. Surprisingly, OSMR KO mice showed a reduc-
tion in subchondral bone and metaphyseal trabecular bone in DMM-
tibiae compared to sham tibiae suggesting that OSMR-mediated sig-
nalling is also critical in limiting bone loss in these conditions.
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CARTILAGE-SPECIFIC DELETION OF MTOR UPREGULATES
AUTOPHAGY AND PROTECTS MICE FROM OSTEOARTHRITIS.
Y. Zhang, F. Vasheghani, Y. Li, M. Blati, S. Kayla, H. Fahmi, B. Lussier,
J-P. Pelletier, J. Martel-Pelletier, M. Kapoor. Univ. of Montreal, Montreal,
QC, Canada
Purpose: Recent studies suggest that the process of autophagy, a form
of programmed cell survival, is impaired during osteoarthritis (OA) and
may contribute towards decreased chondroprotection in the articular
cartilage associated with OA pathophysiology. mTOR (a serine/threo-
nine protein kinase) is a major repressor of autophagy. The exact role of
mTOR in OA pathophysiology is largely unknown. We determined the
expression of mTOR and known autophagy genes in human OA cartilage
as well as mouse and dog models of experimental OA. We also created
cartilage-speciﬁc mTOR knockout (KO) mice to determine the speciﬁc
role of mTOR in OA pathophysiology and autophagy signalling in vivo.
Methods: Human normal and OA cartilage was subjected to human
autophagy PCR array, western blotting, qPCR and immunohistochem-
istry. Inducible cartilage-speciﬁc mTOR KO mice were generated and
subjected to mouse model of OA. Human OA chondrocytes were treated
with rapamycin and ULK1 (most upstream autophagy inducer) SiRNA to
determine mTOR signalling pathway.
Results: mTOR is overexpressed in human OA patient cartilage as well
as mouse and dog experimental OA. Upregulation of mTOR expression
co-relates with increased chondrocyte apoptosis and reduced expres-
sion of key autophagy genes during OA. Subsequently, we show for the
ﬁrst time that cartilage-speciﬁc ablation of mTOR results in increased
autophagy signalling and a signiﬁcant protection from DMM-induced
OA associated with a signiﬁcant reduction in the articular cartilage
degradation, cell death and synovial ﬁbrosis. Furthermore, we show
that mTOR is responsible for shutting down ULK1/autophagy signalling
pathway resulting in the imbalance in the expression of catabolic and
anabolic factors in human OA chondrocytes.
Conclusions: This study for the ﬁrst time provides a direct evidence of
the role of mTOR and its downstream modulation of autophagy in
articular cartilage homeostasis. Thus targeting cellular homeostasis
mediators, such as mTOR and its downstream signaling by ULK1/
autophagy pathwaymay be a promising therapeutic strategy to achieve
chondroprotection and correct the imbalance between catabolic and
anabolic processes during OA and related disorders.
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MITOPHAGY DYSFUNCTION LOCALISES TO REGIONS OF NATURAL
OSTEOARTHRITIS IN STR/ORT MICE
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